Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small...

Area of Science:

• Molecular Biology
• Virology
• Oncology

Background:

• RNA interference (RNAi) is a gene silencing mechanism with therapeutic potential for viral diseases.
• Cervical cancer, often caused by human papillomavirus (HPV), presents a significant global health challenge.
• Viral oncogenes E6 and E7 play crucial roles in HPV-induced cervical carcinogenesis.

Purpose of the Study:

• To investigate the efficacy of RNA interference (RNAi) using small interfering RNA (siRNA) for silencing human papillomavirus (HPV) oncogenes in cervical cancer cells.
• To evaluate the impact of silencing HPV E6 and E7 genes on cellular processes such as cell cycle control and apoptosis.
• To determine the selectivity of siRNA-mediated gene silencing on viral genes versus host cellular genes.

Main Methods:

• Utilizing synthetic small interfering RNA (siRNA) to target messenger RNA (mRNA) of HPV E6 and E7 oncogenes.
• Employing cervical cancer cells as a model system to demonstrate RNA interference.
• Assessing the effects of gene silencing on cellular p53 protein levels, p21 gene expression, cell growth, and apoptotic cell death.

Main Results:

• Successful silencing of HPV E6 and E7 gene expression was achieved using targeted siRNAs.
• E6 silencing led to p53 protein accumulation, p21 gene activation, and reduced cell proliferation.
• E7 silencing induced apoptotic cell death in treated cells.
• HPV-negative cells remained unaffected by the antiviral siRNAs, indicating high specificity.

Conclusions:

• Small interfering RNA (siRNA) is a potent tool for selective gene silencing of exogenous viral oncogenes in mammalian cells.
• RNA interference offers a promising therapeutic strategy for treating virus-induced cancers like cervical cancer.
• The siRNA approach effectively restores normal cellular regulatory functions previously disrupted by viral gene expression.